Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,851 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 887
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +12.2%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 201–221 of 221 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04861584	Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects	recruiting	Phase 2	41	Zhujiang HospitalOTHER	1	Dec 4, 2024	clinicaltrials
NCT06341400	RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients	recruiting	Phase 1 / Phase 2	55	Zhujiang HospitalOTHER	1	Dec 4, 2024	clinicaltrials